Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dowdy

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Model-based Cost-effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York, and TexasYoungji Jo, Sourya Shrestha, Isabella Gomes, et al.
Plos One|September 26, 2022
Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projectsIsabella Gomes, Chaoran Dong, Pauline Vandewalle, et al.
American Journal of Epidemiology|October 13, 2022
Quantifying Mycobacterium tuberculosis Transmission Dynamics Across Global Settings: A Systematic AnalysisJonathan P Smith, Ted Cohen, David Dowdy, et al.
PLOS Global Public Health|February 6, 2026
Combination interventions to control the tuberculosis epidemic in the Karamoja subregion of Uganda: A modelling analysisStella Zawedde-Muyanja, Letisha Najjemba, Tadeo Nsubuga, et al.
Journal of the International AIDS Society|October 19, 2020
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in UgandaOlivia Ferguson, Youngji Jo, Jeff Pennington, et al.
Plos One|November 6, 2018
Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in SpainParastu Kasaie, Matthew Radford, Sunaina Kapoor, et al.
BMC Medicine|August 7, 2019
Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological modelHojoon Sohn, Parastu Kasaie, Emily Kendall, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 25, 2005
Breaking the translational barriers: the value of integrating biomedical informatics and translational researchPhilip R O Payne, Stephen B Johnson, Justin B Starren, et al.
Annals of Internal Medicine|July 7, 2015
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysisOlalekan A Uthman, Charles Okwundu, Kayode Gbenga, et al.
Plos One|September 9, 2021
Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in ZambiaYoungji Jo, Mary Kagujje, Karl Johnson, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Model-based Cost-effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York, and TexasYoungji Jo, Sourya Shrestha, Isabella Gomes, et al.
Plos One|September 26, 2022
Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projectsIsabella Gomes, Chaoran Dong, Pauline Vandewalle, et al.
American Journal of Epidemiology|October 13, 2022
Quantifying Mycobacterium tuberculosis Transmission Dynamics Across Global Settings: A Systematic AnalysisJonathan P Smith, Ted Cohen, David Dowdy, et al.
PLOS Global Public Health|February 6, 2026
Combination interventions to control the tuberculosis epidemic in the Karamoja subregion of Uganda: A modelling analysisStella Zawedde-Muyanja, Letisha Najjemba, Tadeo Nsubuga, et al.
Journal of the International AIDS Society|October 19, 2020
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in UgandaOlivia Ferguson, Youngji Jo, Jeff Pennington, et al.
Plos One|November 6, 2018
Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in SpainParastu Kasaie, Matthew Radford, Sunaina Kapoor, et al.
BMC Medicine|August 7, 2019
Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological modelHojoon Sohn, Parastu Kasaie, Emily Kendall, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 25, 2005
Breaking the translational barriers: the value of integrating biomedical informatics and translational researchPhilip R O Payne, Stephen B Johnson, Justin B Starren, et al.
Annals of Internal Medicine|July 7, 2015
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysisOlalekan A Uthman, Charles Okwundu, Kayode Gbenga, et al.
Plos One|September 9, 2021
Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in ZambiaYoungji Jo, Mary Kagujje, Karl Johnson, et al.
Pageof 11